ZYBT ZHENGYE BIOTECHNOLOGY HLDG L: institutional ownership and insider trading

8 funds reported holding $68.1K of ZHENGYE BIOTECHNOLOGY HLDG L in their latest 13F filings; in Q2 2026 funds net sold $14.1K, with 1 new positions and 1 funds selling out.

Largest institutional holders of ZYBT

  1. XTX Topco Ltd — $33.1K
  2. GEODE CAPITAL MANAGEMENT, LLC — $19.7K
  3. WINTON GROUP Ltd — $8.62K
  4. UBS Group AG (UBS) — $5.41K
  5. ROYAL BANK OF CANADA (RY, RBMCF, RYLBF, RYPBF) — $1.00K
  6. MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $168
  7. JPMORGAN CHASE & CO (JPM, AMJB, VYLD, JPM-PC, JPM-PD, JPM-PJ, JPM-PK, JPM-PL, JPM-PM) — $93
  8. Caitong International Asset Management Co., Ltd — $1

Who owns the most ZYBT stock?

The largest institutional holders of ZHENGYE BIOTECHNOLOGY HLDG L in the latest 13F filings are XTX Topco Ltd ($33.1K), GEODE CAPITAL MANAGEMENT, LLC ($19.7K), WINTON GROUP Ltd ($8.62K).

All ZYBT 13F holders